PLx Pharma Inc. Common Stock
PLXP
PLXP was delisted on the 12th of April, 2023.
27 hedge funds and large institutions have $37.3M invested in PLx Pharma Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 3 closing their positions.
233% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 3
125% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 4
72% more capital invested
Capital invested by funds: $21.7M → $37.3M (+$15.6M)
35% more funds holding
Funds holding: 20 → 27 (+7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCP
Tourbillon Capital Partners
New York
|
+$8.41M |
| 2 |
KCM
Kingdon Capital Management
New York
|
+$3.35M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.68M |
| 4 |
6CM
683 Capital Management
New York
|
+$905K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$532K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO)
Irvine,
California
|
-$374K |
| 2 |
OC
Oppenheimer & Co
New York
|
-$131K |
| 3 |
SIM
Spark Investment Management
New York
|
-$112K |
| 4 |
PCM
Prelude Capital Management
New York
|
-$29K |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$27K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Citigroup
New York
| $3K | +$3.1K | +30 | New |
|
|
FANJ
27
Financial Architects (New Jersey)
Marlton,
New Jersey
| $2K | +$1.97K | +19 | New |
|
|
PAAMCP
28
Pacific Alternative Asset Management Company (PAAMCO)
Irvine,
California
| – | -$374K | -3,425 | Closed |
|
|
29
AllianceBernstein
Nashville,
Tennessee
| – | -$27K | -250 | Closed |
|
|
TRCT
30
Tower Research Capital (TRC)
New York
| – | -$3K | -25 | Closed |
|
PLXP Hedge Fund Activity: Q2 2015 in Review
27 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in PLx Pharma Inc. Common Stock (PLXP) for Q2 2015, worth a combined $37.3M — up 72% from $21.7M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new PLXP positions and 3 closed out — a net gain of 7 holders — while 9 added to existing stakes and 4 trimmed.
The largest buyer was Tourbillon Capital Partners, opening a new position worth an estimated $8.41M. The largest seller was Pacific Alternative Asset Management Company (PAAMCO), exiting entirely with an estimated $374K sold.
- 27 institutional investors held PLx Pharma Inc. Common Stock (PLXP) as of Q2 2015, up from 20 in Q1 2015.
- Funds reported $37.3M of PLx Pharma Inc. Common Stock stock for Q2 2015, up 72% quarter-over-quarter.
- 10 funds opened new PLx Pharma Inc. Common Stock positions in Q2 2015 and 3 closed out, a net change of +7 holders.
- The largest PLx Pharma Inc. Common Stock buyer in Q2 2015 was Tourbillon Capital Partners, an estimated $8.41M added.
- The largest PLx Pharma Inc. Common Stock seller in Q2 2015 was Pacific Alternative Asset Management Company (PAAMCO), an estimated $374K sold.
Based on aggregated 13F filings for Q2 2015.